Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Ameresco
AMRC
$1.37B
| $667K | ﹤0.01% |
38,100
-1,800
| -5% | -$28.3K |
|
|
ATSG
2327
DELISTED
Air Transport Services Group
ATSG
| $667K | ﹤0.01% |
28,450
+900
| +3% | +$20.2K |
|
|
CPRX
2328
DELISTED
Catalyst Pharmaceutical
CPRX
| $665K | ﹤0.01% |
177,300
+5,200
| +3% | +$24.3K |
|
|
ANH
2329
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $665K | ﹤0.01% |
189,000
+3,900
| +2% | +$13.5K |
|
2330
Clearwater Paper
CLW
$366M
| $662K | ﹤0.01% |
31,000
| – | – |
|
2331
Haverty Furniture Companies
HVT
$443M
| $661K | ﹤0.01% |
32,800
| – | – |
|
|
SWIR
2332
DELISTED
Sierra Wireless
SWIR
| $661K | ﹤0.01% |
69,400
+2,600
| +4% | +$25.3K |
|
|
AGS
2333
DELISTED
PlayAGS
AGS
| $659K | ﹤0.01% |
54,300
+1,800
| +3% | +$20.5K |
|
2334
Forestar Group
FOR
$1.48B
| $659K | ﹤0.01% |
31,617
+1,100
| +4% | +$21.5K |
|
2335
FRP Holdings
FRPH
$425M
| $657K | ﹤0.01% |
26,400
+800
| +3% | +$20.1K |
|
|
REVG
2336
DELISTED
REV Group
REVG
| $657K | ﹤0.01% |
53,700
+1,200
| +2% | +$15.2K |
|
|
HA
2337
DELISTED
Hawaiian Holdings, Inc.
HA
| $656K | ﹤0.01% |
22,409
| – | – |
|
2338
Donnelley Financial Solutions
DFIN
$1.16B
| $652K | ﹤0.01% |
62,304
+1,500
| +2% | +$15.7K |
|
2339
Central Garden & Pet Co
CENT
$2.76B
| $651K | ﹤0.01% |
26,188
+875
| +3% | +$20.8K |
|
2340
NVE Corp
NVEC
$565M
| $650K | ﹤0.01% |
9,100
| – | – |
|
2341
BRC Group Holdings
RILY
$292M
| $650K | ﹤0.01% |
25,800
+1,100
| +4% | +$28.9K |
|
|
HUYA
2342
Huya Inc
HUYA
$556M
| $648K | ﹤0.01% |
+36,100
| New | +$763K |
|
2343
Willdan Group
WLDN
$1.28B
| $648K | ﹤0.01% |
20,400
+900
| +5% | +$28.5K |
|
2344
El Pollo Loco
LOCO
$452M
| $647K | ﹤0.01% |
42,750
| – | – |
|
2345
Byline Bancorp
BY
$1.76B
| $642K | ﹤0.01% |
32,800
+700
| +2% | +$12.8K |
|
2346
Clean Energy Fuels
CLNE
$377M
| $642K | ﹤0.01% |
274,258
+9,200
| +3% | +$19.5K |
|
2347
Blue Bird Corp
BLBD
$2.1B
| $640K | ﹤0.01% |
27,911
+900
| +3% | +$18K |
|
2348
VSE Corp
VSEC
$6.79B
| $639K | ﹤0.01% |
16,800
+400
| +2% | +$14.9K |
|
2349
Sonos
SONO
$1.78B
| $636K | ﹤0.01% |
40,700
+1,400
| +4% | +$19.5K |
|
|
EXK
2350
Endeavour Silver
EXK
$3.14B
| $635K | ﹤0.01% |
263,900
+17,700
| +7% | +$40.2K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.